ISSN: 0167-594X

Journal Guideline

Journal of Neuro-Oncology Q1 Unclaimed

Kluwer Academic Publishers Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.Why publish with us A unified resource for multi-disciplinary clinicians and researchers in neuro-oncology. In our special topical issues, global experts address current challenges and contemporary topics. Our internationally renowned advisers collaborate to deliver quick first decisions to authors and rapid publication. We provide high levels of author satisfaction, with 92% of our published authors reporting that they would definitely or probably publish with us again. It has an SJR impact factor of 1,178.

Journal of Neuro-Oncology focuses its scope in these topics and keywords: glioblastoma, tumor, brain, cell, patients, human, glioma, study, cancer, factor, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Neurology (Q1) Neurology (clinical) (Q1) Neurology (clinical) (Q1) Oncology (Q1) Cancer Research (Q2)

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,178

SJR Impact factor

129

H Index

301

Total Docs (Last Year)

837

Total Docs (3 years)

11965

Total Refs

3384

Total Cites (3 years)

810

Citable Docs (3 years)

3.68

Cites/Doc (2 years)

39.75

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
Molecular Cancer Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

Two Different Mechanisms of Apoptosis Resistance Observed in Interferon- Induced Apoptosis of Human Glioma Cells

CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component

Unusual Metastatic Features in a Patient with Concomitant Malignant Orbital Melanoma and Prostate Carcinoma

The Effects of Antisense AKT2 RNA on the Inhibition of Malignant Glioma Cell Growth in vitro and in vivo

Ganglioneurocytoma of the Third Ventricle

Toxicity and Cerebrospinal Fluid Levels of Carboplatin Chronically Infused into the Brainstem of a Primate

Malignant Intracranial Epithelioid Hemangioendothelioma Presumably Originating from the Lung: Case Report

Neuro-Oncology in a Nutshell

Single Brain Metastases of Carcinoid Tumors

Epithelioid Hemangioendothelioma of the Infundibular-Hypothalamic Region: Case Report and Literature Review

Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma

Assessment of tumor cell invasion factors in gliomatosis cerebri

SHOW MORE ARTICLES

CXCL12 in Malignant Glial Tumors: A Possible Role in Angiogenesis and Cross-Talk between Endothelial and Tumoral Cells

Advances in surgical management of malignancies of the cranial base: the extended transbasal approach

A Prospective Blinded Study of the Predictive Value of an Extreme Drug Resistance Assay in Patients Receiving CPT-11 for Recurrent Glioma

Delayed Radiation Toxicity after Focal or Whole Brain Radiotherapy for Low-Grade Glioma

Primary Leptomeningeal Sarcomatosis; A Pathology Proven Case with Challenging MRI and Clinical Findings

Radiation-induced Tumor after Stereotactic Radiosurgery and Whole Brain Radiotherapy: Case Report and Literature Review

Molecular Genetic Study of a Metastatic Oligodendroglioma

Apoptosis and proliferation: correlation with p53 in astrocytic tumours

Primary malignant rhabdoid tumor of the central nervous system -a comprehensive review

Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study

Images in Neuro-Oncology

Correction to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI